[go: up one dir, main page]

AU8121391A - Self-sticking matrix system for the sustained transcutaneous release of piribedil - Google Patents

Self-sticking matrix system for the sustained transcutaneous release of piribedil

Info

Publication number
AU8121391A
AU8121391A AU81213/91A AU8121391A AU8121391A AU 8121391 A AU8121391 A AU 8121391A AU 81213/91 A AU81213/91 A AU 81213/91A AU 8121391 A AU8121391 A AU 8121391A AU 8121391 A AU8121391 A AU 8121391A
Authority
AU
Australia
Prior art keywords
piribedil
self
sustained
matrix system
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU81213/91A
Other versions
AU635653B2 (en
Inventor
Francoise Arnaud
Claire Chezaubernard
Alain Cuine
Yvonne Evrard
Isabelle Rault
Jean-Marc Rollot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of AU8121391A publication Critical patent/AU8121391A/en
Application granted granted Critical
Publication of AU635653B2 publication Critical patent/AU635653B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention relates to a self-adhesive silicone elastomer matrix system for the sustained release of piribedil, which provides for the continuous and steady transdermal diffusion of piribedil.
AU81213/91A 1990-07-23 1991-07-22 Self-sticking matrix system for the sustained transcutaneous release of piribedil Ceased AU635653B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9009361A FR2664815B1 (en) 1990-07-23 1990-07-23 SELF-ADHESIVE MATRIX SYSTEM FOR THE EXTENDED RELEASE OF THE PIRIBEDIL BY TRANSCUTANEOUS ROUTE.
FR9009361 1990-07-23

Publications (2)

Publication Number Publication Date
AU8121391A true AU8121391A (en) 1992-01-30
AU635653B2 AU635653B2 (en) 1993-03-25

Family

ID=9398984

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81213/91A Ceased AU635653B2 (en) 1990-07-23 1991-07-22 Self-sticking matrix system for the sustained transcutaneous release of piribedil

Country Status (15)

Country Link
EP (1) EP0468875B1 (en)
JP (1) JPH04234322A (en)
AT (1) ATE124271T1 (en)
AU (1) AU635653B2 (en)
CA (1) CA2047508A1 (en)
DE (1) DE69110781T2 (en)
DK (1) DK0468875T3 (en)
ES (1) ES2075942T3 (en)
FR (1) FR2664815B1 (en)
GR (1) GR3017276T3 (en)
IE (1) IE912577A1 (en)
NZ (1) NZ239074A (en)
OA (1) OA09384A (en)
PT (1) PT98416B (en)
ZA (1) ZA915769B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2675383B1 (en) * 1991-04-18 1995-05-12 Bernard Aranda USE OF A MEDICINAL PRODUCT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HYPERACTIVE OR UNSTABLE BLADDER.
FR2691361B1 (en) * 1992-05-19 1994-07-08 Adir SELF-ADHESIVE MATRIX SYSTEM FOR THE EXTENDED RELEASE OF THE PIRIBEDIL BY TRANSCUTANEOUS ROUTE.
DE19512181C2 (en) 1995-03-31 2003-11-06 Hexal Pharma Gmbh Transdermal system with ramipril and / or trandolapril as an ACE inhibitor
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
AU759515B2 (en) * 1999-02-05 2003-04-17 Cipla Limited Topical sprays comprising a film forming composition
TWI277418B (en) 2001-06-18 2007-04-01 Noven Pharma Enhanced drug delivery in transdermal systems
US6805878B2 (en) 2001-09-13 2004-10-19 Noven Pharmaceuticals, Inc. Transdermal administration of ACE inhibitors
CN105267173A (en) * 2014-05-30 2016-01-27 北京星昊医药股份有限公司 Piribedil sustained-release tablets and preparation method thereof
MX2017005399A (en) 2014-10-30 2017-07-26 Textile-Based Delivery Inc Delivery systems.
CN105232475A (en) * 2015-11-19 2016-01-13 哈尔滨圣吉药业股份有限公司 Piribedil controlled-release pellets and preparing method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2519986A1 (en) * 1982-01-21 1983-07-22 Adir NOVEL BENZODIOXINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
DE3344691A1 (en) * 1983-12-10 1985-06-20 Bayer Ag, 5090 Leverkusen ACTIVE GAS EXHAUST SYSTEMS
EP0196769B1 (en) * 1985-02-25 1992-07-08 Rutgers, The State University of New Jersey A novel transdermal pharmaceutical absorption dosage unit
HU197519B (en) * 1987-06-22 1989-04-28 Biogal Gyogyszergyar Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade
FR2619388A1 (en) * 1987-08-14 1989-02-17 Rhone Poulenc Chimie SOFT LAMINATE ARTICLE FOR TRANSFER ADHESIVE

Also Published As

Publication number Publication date
PT98416B (en) 1999-01-29
EP0468875B1 (en) 1995-06-28
EP0468875A2 (en) 1992-01-29
CA2047508A1 (en) 1992-01-24
IE912577A1 (en) 1992-01-29
ATE124271T1 (en) 1995-07-15
FR2664815A1 (en) 1992-01-24
DE69110781D1 (en) 1995-08-03
OA09384A (en) 1992-09-15
ZA915769B (en) 1992-05-27
NZ239074A (en) 1992-10-28
GR3017276T3 (en) 1995-11-30
JPH04234322A (en) 1992-08-24
ES2075942T3 (en) 1995-10-16
EP0468875A3 (en) 1992-04-01
DE69110781T2 (en) 1995-11-23
PT98416A (en) 1994-01-31
DK0468875T3 (en) 1995-11-20
FR2664815B1 (en) 1994-11-04
AU635653B2 (en) 1993-03-25

Similar Documents

Publication Publication Date Title
AU6569694A (en) Active substance-containing plaster
BG102200A (en) Transcorneal system for the release of a medicament
AU635358B2 (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
EP0641848A3 (en) Silicone pressure-sensitive adhesives
AU6385486A (en) Sustained release composition
DE3850746D1 (en) Ostomy device and convex pressure ring therefor.
AU7211287A (en) Controlled release drug delivery system for the peridontal pocket
AU8121391A (en) Self-sticking matrix system for the sustained transcutaneous release of piribedil
AU7526294A (en) Class i mhc modulation of surface receptor activity
PL307562A1 (en) Dyeing agents for ceratine containing fibres
AU4538797A (en) Plasters containing active substances
MY102046A (en) Compartmentalized transdermal delivery system.
PL323145A1 (en) Transcutaneous therapeutic system (tts) for administering testosterone
AU1463088A (en) Receptor of the small rhinovirus receptor group
AU656266B2 (en) Self-sticking matrix system for the sustained transcutaneous release of piribedil
ES2013025A6 (en) 24r-scymnol, and preparation and use thereof.
EP0634168A4 (en)
MY109468A (en) Sangkar balut buah-buahan
MX9706424A (en) Use of moxonidine for the treatment of atherosclerosis.
ES2149644A1 (en) Guide device for mounting embedded lamps and similar elements
BR9811645A (en) Patient support equipment